mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.02 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |